Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
TEVA PHARMA
Dec-13
ALKEM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,6253,479-   
Low Rs2,8353,022-   
Sales per share (Unadj.) Rs970.11,996.4-  
Earnings per share (Unadj.) Rs84.2124.7-  
Cash flow per share (Unadj.) Rs110.2286.1-  
Dividends per share (Unadj.) Rs50.00109.18-  
Avg Dividend yield %1.53.4 46.1%  
Book value per share (Unadj.) Rs756.42,217.6-  
Shares outstanding (eoy) m119.57848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.31.6 204.5%   
Avg P/E ratio x38.426.1 147.2%  
P/CF ratio (eoy) x29.311.4 258.1%  
Price / Book Value ratio x4.31.5 291.3%  
Dividend payout %59.487.5 67.8%   
Avg Mkt Cap Rs m386,2072,756,220 14.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m21,3140-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m115,9931,692,969 6.9%  
Other income Rs m2,1610-   
Total revenues Rs m118,1531,692,969 7.0%   
Gross profit Rs m15,065463,620 3.2%  
Depreciation Rs m3,104136,844 2.3%   
Interest Rs m1,07433,253 3.2%   
Profit before tax Rs m13,048293,523 4.4%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m2,980-3,584 -83.1%   
Profit after tax Rs m10,068105,758 9.5%  
Gross profit margin %13.027.4 47.4%  
Effective tax rate %22.8-1.2 -1,870.4%   
Net profit margin %8.76.2 138.9%  
BALANCE SHEET DATA
Current assets Rs m86,0641,143,425 7.5%   
Current liabilities Rs m37,071997,163 3.7%   
Net working cap to sales %42.28.6 488.9%  
Current ratio x2.31.1 202.5%  
Inventory Days Days3391 35.9%  
Debtors Days Days6796 70.0%  
Net fixed assets Rs m37,245552,961 6.7%   
Share capital Rs m2394,167 5.7%   
"Free" reserves Rs m90,2080-   
Net worth Rs m90,4471,880,567 4.8%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m124,5413,868,976 3.2%  
Interest coverage x13.29.8 133.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 212.8%   
Return on assets %8.93.6 249.0%  
Return on equity %11.15.6 197.9%  
Return on capital %15.64.9 316.6%  
Exports to sales %14.60-   
Imports to sales %00-   
Net fx Rs m12,7270-   
CASH FLOW
From Operations Rs m16,825269,772 6.2%  
From Investments Rs m1,128-95,591 -1.2%  
From Financial Activity Rs m-17,608-323,609 5.4%  
Net Cashflow Rs m416-149,429 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALKEM LABORATORIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALKEM LABORATORIES With: FABINO LIFE   BDH INDUS.  VINEET LABORATORIES  DECIPHER LABS  IND. SWIFT  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.